These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Quality control of infusion solutions. I. Foreign particles in infusion solutions]. van den Bemd AA Pharm Weekbl; 1969 Sep; 104(39):1205-9. PubMed ID: 5345140 [No Abstract] [Full Text] [Related]
12. [Special problems in the development of modern infusion solutions]. Frank P Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Mar; 40(3):77-88. PubMed ID: 5467832 [No Abstract] [Full Text] [Related]
14. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations. Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622 [No Abstract] [Full Text] [Related]
15. Qaulity-control plan for intravenous admixture programs. II: Validation of operator technique. Morris BG; Avis KE; Bowles GC Am J Hosp Pharm; 1980 May; 37(5):668-72. PubMed ID: 7386475 [TBL] [Abstract][Full Text] [Related]
16. Joint commission to survey compliance with new USP-NF Chapter on compounding sterile preparations. Jt Comm Perspect; 2004 Apr; 24(4):4-5. PubMed ID: 15085694 [No Abstract] [Full Text] [Related]
17. Parenteral Drug Association response to FDA proposal to prohibit the use of any antimicrobial preservative in single-dose parenteral drug products. J Parenter Sci Technol; 1985; 39(6):231-2. PubMed ID: 4093824 [No Abstract] [Full Text] [Related]
18. Current good manufacturing practices for PET drug products in the United States. Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213 [No Abstract] [Full Text] [Related]
19. [Parenteral administration medicines: recommendations of preparation, administration and stability]. Gaspar Carreño M; Torrico Martín F; Novajarque Sala L; Batista Cruz M; Ribeiro Gonçalves P; Porta Oltra B; Sánchez Santos JC Farm Hosp; 2014 Nov; 38(6):461-7. PubMed ID: 25542656 [TBL] [Abstract][Full Text] [Related]
20. Automatic pipetters: applications and cost considerations in I.V. admixture programs. Blackstone M; Hauser LD Hosp Mater Manage Q; 1980 Feb; 1(3):69-85. PubMed ID: 10309094 [No Abstract] [Full Text] [Related] [Next] [New Search]